glp-1 therapy madisonville Buddy GLP-1 Weight Loss Plans
Description
Among frequent issues cited in the adverse event reports were administration of an extra or incorrect dose, issues with communication about a product, and prescribing errors
Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database
Medicina (B Aires) 2024;60:2030
Contact us!
